Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences, Inc shares valued at $1,139,370 were sold by O’Day Daniel Patrick on Jul 28 ’25. At $113.94 per share, O’Day Daniel Patrick sold 10,000 shares. The insider’s holdings dropped to 605,725 shares worth approximately $72.77 million following the completion of this transaction.
Also, DANIEL ODAY purchased 10,000 shares, netting a total of over 1,139,369 in proceeds.
Before that, Mercier Johanna had sold 3,000 shares from its account. In a trade valued at $333,090, the Chief Commercial Officer traded Gilead Sciences, Inc shares for $111.03 each. Upon closing the transaction, the insider’s holdings decreased to 3,000 shares, worth approximately $14.08 million.
As published in a research note from Truist on August 08, 2025, Gilead Sciences, Inc [GILD] has been rated up from a Hold to a Buy and the price target has been revised to $127. Analysts at Needham upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in late July. Earlier on March 04, 2025, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for GILD stock.
Analyzing GILD Stock Performance
On last trading session, Gilead Sciences, Inc [NASDAQ: GILD] rose 0.10% to $120.14. The stock’s lowest price that day was $119.5, but it reached a high of $121.11 in the same session. During the last five days, there has been a surge of approximately 8.94%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 63.10%. Shares of the company reached a 52-week high of $121.83 on 08/12/25 and a 52-week low of $88.57 on 01/10/25.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 119.39, which, if violated, would cause prices to drop to 118.63. In the upper region, resistance lies at 121.01. The next price resistance is at 121.87. RSI (Relative Strength Index) is 63.87 on the 14-day chart, showing neutral technical sentiment.
Is Gilead Sciences, Inc subject to short interest?
Stocks of Gilead Sciences, Inc saw a sharp steep in short interest on 2025-07-31 dropping by -1.0 million shares to 19.99 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 20.99 million shares. A decline of -5.01% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.54 of the overall float, the days-to-cover ratio (short ratio) decline to 3.54.
Which companies own the most shares of Gilead Sciences, Inc (GILD)?
In terms of Gilead Sciences, Inc share price expectations, FactSet research, analysts set an average price target of 126 in the next 12 months, up nearly 4.98% from the previous closing price of $120.02. Analysts anticipate Gilead Sciences, Inc stock to reach 143 by 2025, with the lowest price target being 108. In spite of this, 17 analysts ranked Gilead Sciences, Inc stock as Buy at the end of 2025. On February 18, 2025, Deutsche Bank assigned a price target of “a Buy” to the stock and upgraded coverage with a $120.
